Center for Addiction and Disease Risk Exacerbation
成瘾和疾病风险加剧中心
基本信息
- 批准号:10624495
- 负责人:
- 金额:$ 32.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlcoholsApplications GrantsBehavioralBiological MarkersBrainBusinessesCannabisCarcinogen exposureCardiac healthCenters of Research ExcellenceChronicChronic DiseaseClinicalCommunitiesDatabasesDevelopmentDiscipline of NursingDiseaseDoctor of PharmacyDoctor of PhilosophyElectronic cigaretteEnsureEnvironmentEvaluationExperimental DesignsExtramural ActivitiesFacultyFundingFutureGoalsGrantHIVHIV InfectionsHealthHuman ResourcesImmune System DiseasesIndividualInflammationInflammatoryInfrastructureInterventionKnowledgeLaboratoriesLeadLeadershipLearningLinkLiteratureMagnetic Resonance ImagingManuscriptsMeasuresMediatingMedicalMentorsMissionNeurosciencesOpioidOutcomeOxytocinPainPatientsPeer ReviewPersonsPharmaceutical PreparationsPharmacotherapyPhasePhysiologicalPilot ProjectsPostdoctoral FellowPreparationPrevalencePreventionPrevention approachPsychologyPublicationsRelapseResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesRheumatoid ArthritisRiskRisk FactorsRisk ManagementRoleScientistServicesSmokerSmokingStressStructureSubstance Use DisorderSubstance abuse problemSubstance of AbuseTobaccoTrainingTranslational ResearchTryptophanUniversitiesWorkaddictionarthritic painbasebiobehaviorcigarette smokingcombustible cigarettecommunecost effectivenesscytokinedesigndisorder riskexperiencefaculty mentorhealth disparityinnovationinsightinterestlung healthmicrobialmonocytemultidisciplinarynegative affectnext generationnovel strategiesopioid use disorderorganizational structurepatient populationprogramsracial and ethnic disparitiesrecruitresponsesocioeconomicssubstance use
项目摘要
Project Summary/Abstract
Substance use (SU) negatively affects the risk, management, progression, and outcomes of chronic disease and
contributes to socio-economic and racial/ethnic disparities. Prevalence rates of medical conditions among
patients with versus those without substance abuse disorders (SUDs) support this thesis. Furthermore, risks are
exacerbated among those at risk for or who already have chronic medical conditions, such as people living with
HIV. Though linkages between SU and disease are well documented, physiological mechanisms underlying
linkages are poorly understood, largely because the literature is based on studies that use cross-sectional
designs that do not allow for causal interpretations. Studies using experimental designs are needed to
understand mechanisms that link SU and disease and to inform the development of targeted prevention and
intervention efforts to reduce risks. We propose to establish a COBRE Center for Addiction and Disease Risk
Exacerbation (CADRE) that will investigate mechanisms whereby SU impacts disease, using a combination of
behavioral and physiological laboratory-based approaches across several substances of abuse. CADRE
consists of four thematically and technically-linked research projects (RPs) led by an interdisciplinary group of
junior faculty. Monnig will examine effects of HIV and alcohol on markers of microbial translocation, monosite
activation, cytokine response, tryptophan degradation and MRI measures of inflammation. Haass-Koffler will
examine the initial efficacy of oxytocin as a potential pharmacotherapy for OUD targeting stress in opioid relapse.
Cioe will study effects of e-cigarettes on combustible cigarette smoking, biomarkers of smoking-related cardiac
and pulmonary health, and carcinogen exposure in smokers with HIV. Aston examines effects of cannabis on
RA pain, affect, and inflammation, and investigates whether effects of cannabis on pain and affect are mediated
via effects of cannabis on inflammatory biomarkers. An Administrative Core will provide organizational structure,
state-of-the-art mentoring, a pilot program, support diversity and health disparities work, and lead evaluation. A
Clinical Laboratory Core will facilitate goals of the RPs and pilot projects, and benefit the broader Brown
community by providing infrastructure and resources in the service of developing and sustaining a multi-
disciplinary center. It will maximize efficiency and cost-effectiveness of this COBRE by creating linkages between
CADRE RPs and other COBREs, and will create a center-wide data base of risk factors associated with
development and progression of SUDs and chronic disease, available to CADRE Project Leaders (PLs) and
others engaged in relevant research. PLs and pilot PLs will benefit from interdisciplinary faculty mentors who
will provide guidance on research, publication, and grant preparation. The basic tenet of the proposed COBRE
CADRE is that innovative interdisciplinary translational research, conducted across multiple levels of analysis,
and focused on related questions using common resources and learning experiences, can not only contribute
new knowledge, but also serves as the nexus and path toward independence for the next generation of scientists.
项目摘要/摘要
物质使用(SU)对慢性疾病的风险,管理,进展和结果负面影响
有助于社会经济和种族/种族差异。医疗状况的患病率
与没有药物滥用障碍的患者(SUD)支持这一论文。此外,风险是
在有危险或已经患有慢性病的人中,例如与之相处的人
艾滋病病毒。尽管SU与疾病之间的联系有充分的文献记载,但生理机制
链接的理解很少,主要是因为文献是基于使用横截面的研究
不允许因果解释的设计。需要使用实验设计的研究
了解将SU和疾病联系起来的机制,并告知有针对性的预防和
干预措施降低风险。我们建议建立一个成瘾和疾病风险的鞋底中心
加剧(干部)将研究机制,从而使SU使用的机制影响疾病
涉及几种滥用物质的行为和生理实验室方法。干部
由四个主题和技术链接的研究项目(RPS)组成
初级教师。 Monnig将检查艾滋病毒和酒精对微生物易位,单材标记的影响
激活,细胞因子反应,色氨酸降解和炎症的MRI测量。哈斯·科夫勒(Haass-Koffler)
检查催产素作为潜在的药物疗法的初始功效,以靶向阿片类药物复发中的应激。
CIOE将研究电子烟对可燃香烟吸烟的影响,与吸烟有关的心脏标志物
艾滋病毒吸烟者的肺部健康和致癌物暴露。阿斯顿研究大麻对
RA疼痛,影响和炎症,并研究大麻对疼痛和影响的影响是否介导
通过大麻对炎症生物标志物的影响。行政核心将提供组织结构,
最先进的指导,试点计划,支持多样性和健康差异以及领导评估。一个
临床实验室核心将促进RP和试点项目的目标,并使更广泛的棕色受益
通过提供基础设施和资源来服务和维持多种多样的社区
纪律中心。它将通过在之间建立联系
干部RPS和其他Cobres,将创建与风险因素的中心数据库
Cadre项目领导者(PLS)和
其他人从事相关研究。 PLS和PILOT PLS将受益于跨学科的教师导师
将提供有关研究,出版和赠款准备的指导。拟议的毛绒的基本宗旨
干部是跨多个分析的创新跨学科翻译研究,
并专注于使用共同资源和学习经验的相关问题,不仅可以做出贡献
新知识,但也充当下一代科学家的独立性的联系和道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER M. MONTI其他文献
PETER M. MONTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER M. MONTI', 18)}}的其他基金
Center for Addiction and Disease Risk Exacerbation
成瘾和疾病风险加剧中心
- 批准号:
10666592 - 财政年份:2019
- 资助金额:
$ 32.9万 - 项目类别:
Center for Addiction and Disease Risk Exacerbation
成瘾和疾病风险加剧中心
- 批准号:
10259689 - 财政年份:2019
- 资助金额:
$ 32.9万 - 项目类别:
Alcohol Intervention Treatment Outcome Research Training
酒精干预治疗结果研究培训
- 批准号:
9389115 - 财政年份:2016
- 资助金额:
$ 32.9万 - 项目类别:
Mechanisms of acute alcohol effects on high risk behaviors in HIV-vulnerable men.
急性酒精对艾滋病毒易感男性高危行为的影响机制。
- 批准号:
8838921 - 财政年份:2015
- 资助金额:
$ 32.9万 - 项目类别:
Alcohol and HIV: Biobehavioral Interactions and Intervention
酒精和艾滋病毒:生物行为相互作用和干预
- 批准号:
7834203 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
Advancing a Bio-Psycho-Social Alcohol Treatment Research and Mentoring Program
推进生物心理社会酒精治疗研究和指导计划
- 批准号:
8321083 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
Alcohol and HIV: Biobehavioral Interactions and Intervention
酒精和艾滋病毒:生物行为相互作用和干预
- 批准号:
8153138 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
Alcohol and HIV: Biobehavioral Interactions and Interventions
酒精和艾滋病毒:生物行为相互作用和干预措施
- 批准号:
9493323 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
Advancing a Bio-Psycho-Social Alcohol Treatment Research and Mentoring Program
推进生物心理社会酒精治疗研究和指导计划
- 批准号:
8133996 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
Alcohol and HIV: Biobehavioral Interactions and Intervention
酒精和艾滋病毒:生物行为相互作用和干预
- 批准号:
8531064 - 财政年份:2010
- 资助金额:
$ 32.9万 - 项目类别:
相似国自然基金
人参皂苷Rg5分子尺度调控脂质代谢改善非酒精性脂肪性肝炎机制
- 批准号:22378329
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
GW441756基于重塑Thrap3转录调控网络改善非酒精性脂肪肝的新机制
- 批准号:82304586
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从AMPK调控线粒体裂变和融合研究金钗石斛总生物碱抗非酒精性脂肪肝病的分子机制
- 批准号:82360808
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Identifying how alcohol-evoked changes in neural firing affect systems level computations during decision-making
确定酒精引起的神经放电变化如何影响决策过程中的系统级计算
- 批准号:
10766877 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
- 批准号:
10664454 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Mitochondrial-Targeted Therapy for Macular Degeneration
线粒体靶向治疗黄斑变性
- 批准号:
10602150 - 财政年份:2023
- 资助金额:
$ 32.9万 - 项目类别:
Norepinephrine modulates medial prefrontal cortex neural ensembles that control cocaine seeking behavior
去甲肾上腺素调节控制可卡因寻求行为的内侧前额皮质神经元
- 批准号:
10348917 - 财政年份:2022
- 资助金额:
$ 32.9万 - 项目类别: